In blood, expression of surface SIGLEC-1 is restricted to CD14+ monocytes, and has been previously reported to be increased in several other autoimmune diseases, including rheumatoid arthritis [17], systemic sclerosis (SSc) [18] and primary biliary cirrhosis [19]. This evidence concerns the gene SIGLEC1 and systemic sclerosis.